Tue, 07 Oct 2008 14:41:10 -0400 PeerView Press http://www.peerviewpress.com Podcast Maker v1.3.3 - http://www.lemonzdream.com/podcastmaker PeerView Press is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. Thought leader perspectives on current clinical advances in medicine PeerView Press is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. 2006 PeerView Press, 24 West 40th Street, Suite 950, New York, NY 10018 webmaster@peerviewpress.com http://podcast.peerviewpress.com/psychiatry/podcast_psychiatry_CME_CE_144.jpg http://www.peerviewpress.com 144 144 Science & Medicine CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Psychiatry no PeerView Press In this case-based CME activity, an expert on the diagnosis and management of bipolar disorder, schizophrenia, and schizoaffective disorder reviews the application of evidence-based best practices to real-world examples of these disorders. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this case-based CME activity, an expert on the diagnosis and management of bipolar disorder, schizophrenia, and schizoaffective disorder reviews the application of evidence-based best practices to real-world examples of these disorders. http://podcast.peerviewpress.com/psychiatry/PA05020FCp149.mp3 http://podcast.peerviewpress.com/psychiatry/PA05020FCp149.mp3 Tue, 30 Sep 2008 14:35:02 -0400 Science no 00:21:08 Psychosis, bipolar disorder, mania, depression, schizoaffective disorder, delusions, hallucinations, lithium, valproate, lamotrigine, carbemezepine ER, agitation PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/psychiatry/PA05020FCCMEinfo.pdf http://podcast.peerviewpress.com/psychiatry/PA05020FCCMEinfo.pdf Tue, 30 Sep 2008 14:34:49 -0400 Science no 00:00:00 Psychosis, bipolar disorder, mania, depression, schizoaffective disorder, delusions, hallucinations, lithium, valproate, lamotrigine, carbemezepine ER, agitation PeerView Press In this CME/CE activity, experts in the treatment of insomnia present recent data on the management of insomnia, including implications for older adults. New data on insomnia in women is also highlighted. In this CME/CE activity, experts in the treatment of insomnia present recent data on the management of insomnia, including implications for older adults. New data on insomnia in women is also highlighted. In this CME/CE activity, experts in the treatment of insomnia present recent data on the management of insomnia, including implications for older adults. New data on insomnia in women is also highlighted. http://podcast.peerviewpress.com/psychiatry/PA04505FCs477.mp3 http://podcast.peerviewpress.com/psychiatry/PA04505FCs477.mp3 Thu, 31 Jul 2008 12:01:00 -0400 Science no 00:25:00 Insomnia, rebound insomnia, anxiety, depression, ramelteon, zolpidem, doxepin, cognitive-behavioral therapy, prescription drugs PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/psychiatry/PA04505FCCMEinfo.pdf http://podcast.peerviewpress.com/psychiatry/PA04505FCCMEinfo.pdf Thu, 31 Jul 2008 12:00:00 -0400 Science no 00:00:00 Insomnia, rebound insomnia, anxiety, depression, ramelteon, zolpidem, doxepin, cognitive-behavioral therapy, prescription drugs PeerView Press In this CME activity, an expert in the treatment of bipolar disorder presents recent data on nonadherence and the efficacy of antipsychotic agents that may be used to treat this condition. Other steps to improve adherence are also highlighted. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this CME activity, an expert in the treatment of bipolar disorder presents recent data on nonadherence and the efficacy of antipsychotic agents that may be used to treat this condition. Other steps to improve adherence are also highlighted. http://podcast.peerviewpress.com/psychiatry/PA04920FCn192.mp3 http://podcast.peerviewpress.com/psychiatry/PA04920FCn192.mp3 Mon, 07 Jul 2008 16:41:11 -0400 Science no 00:26:36 Adherence, acute phase, maintenance phase, antipsychotics, lithium, valproate, divalproex, risperidone, quetiapine, ziprasidone, aripiprazole, olanzapine PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/psychiatry/PA04920FCCMEinfo.pdf http://podcast.peerviewpress.com/psychiatry/PA04920FCCMEinfo.pdf Mon, 07 Jul 2008 16:40:12 -0400 Science no 00:00:00 Adherence, acute phase, maintenance phase, antipsychotics, lithium, valproate, divalproex, risperidone, quetiapine, ziprasidone, aripiprazole, olanzapine PeerView Press Schizophrenia is rare in childhood, but its prevalence steadily increases during adolescence. Many of the symptoms associated with schizophrenia are relatively common and nonspecific; the differential diagnosis of schizophrenia is broad. The use of atypical antipsychotics has shown positive results in adults with schizophrenia. Relatively few data are available on the effectiveness of these agents in children and adolescents. However, a number of recent studies have shown some promising results and have added to this small body of evidence. Please be sure to view the accompanying (PDF) file for full CME/CE information. Schizophrenia is rare in childhood, but its prevalence steadily increases during adolescence. Many of the symptoms associated with schizophrenia are relatively common and nonspecific; the differential diagnosis of schizophrenia is broad. The use of atypical antipsychotics has shown positive results in adults with schizophrenia. Relatively few data are available on the effectiveness of these agents in children and adolescents. However, a number of recent studies have shown some promising results and have added to this small body of evidence. http://podcast.peerviewpress.com/psychiatry/PA04389FCp139.mp3 http://podcast.peerviewpress.com/psychiatry/PA04389FCp139_2.mp3 Fri, 18 Apr 2008 10:25:33 -0400 Science no 00:24:17 Children, adolescents, risperidone, schizophrenia, aripiprazole, clozapine, atypicals, weight gain, hyperprolactinemia, quetiapine, olanzapine PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/psychiatry/PA04389FCCMEinfo.pdf http://podcast.peerviewpress.com/psychiatry/PA04389FCCMEinfo_2.pdf Fri, 18 Apr 2008 10:24:34 -0400 Science no 00:00:00 Children, adolescents, risperidone, schizophrenia, aripiprazole, clozapine, atypicals, weight gain, hyperprolactinemia, quetiapine, olanzapine PeerView Press In this CME activity, experts in fibromyalgia discuss its diagnosis and management. Current theories on the mechanisms of fibromyalgia are highlighted. Strategies for collaboration between multiple specialties in the treatment of patients with fibromyalgia are also featured. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this CME activity, experts in fibromyalgia discuss its diagnosis and management. Current theories on the mechanisms of fibromyalgia are highlighted. Strategies for collaboration between multiple specialties in the treatment of patients with fibromyalgia are also featured. http://podcast.peerviewpress.com/psychiatry/PA04160FCe009.mp3 http://podcast.peerviewpress.com/psychiatry/PA04160FCe009_2.mp3 Thu, 31 Jan 2008 13:11:56 -0500 Science no 00:57:13 Fibromyalgia, FMS, Myofascial pain syndrome, Chronic fatigue syndrome, Hypothyroidism, Depression, Posttraumatic stress disorder, ACR criteria, Genetic factors, Central sensitization, Pregabalin, Duloxetine, Milnacipran, Tricyclic antidepressants PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/psychiatry/PA04160FCCMEinfo.pdf http://podcast.peerviewpress.com/psychiatry/PA04160FCCMEinfo_2.pdf Thu, 31 Jan 2008 13:11:54 -0500 Science no 00:00:00 Fibromyalgia, FMS, Myofascial pain syndrome, Chronic fatigue syndrome, Hypothyroidism, Depression, Posttraumatic stress disorder, ACR criteria, Genetic factors, Central sensitization, Pregabalin, Duloxetine, Milnacipran, Tricyclic antidepressants PeerView Press In this educational activity, psychiatric experts discuss the prevalence, clinical presentation, and prognosis of early-onset schizophrenia. In addition, management issues, including the efficacy and safety of antipsychotic therapies and the integration of support therapies, are presented. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this educational activity, psychiatric experts discuss the prevalence, clinical presentation, and prognosis of early-onset schizophrenia. In addition, management issues, including the efficacy and safety of antipsychotic therapies and the integration of support therapies, are presented. http://podcast.peerviewpress.com/psychiatry/PA03919FCr337.mp3 http://podcast.peerviewpress.com/psychiatry/PA03919FCr337.mp3 Wed, 24 Oct 2007 15:06:49 -0400 Science no 00:45:15 American Academy of Child and Adolescent Psychiatry (AACAP), Antipsychotic, atypical, Aripiprazole, Clozapine, Haloperidol, Olanzapine, Quetiapine, Risperidone, Schizophrenia, early-onset PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/psychiatry/PA03919FCCMEinfo.pdf http://podcast.peerviewpress.com/psychiatry/PA03919FCCMEinfo.pdf Wed, 24 Oct 2007 15:06:42 -0400 Science no 00:00:00 American Academy of Child and Adolescent Psychiatry (AACAP), Antipsychotic, atypical, Aripiprazole, Clozapine, Haloperidol, Olanzapine, Quetiapine, Risperidone, Schizophrenia, early-onset PeerView Press In this activity, two expert psychiatrists and an endocrinologist discuss the prevalence and recognition of hyperprolactinemia in patients receiving antipsychotic medications and management strategies for reducing this risk. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, two expert psychiatrists and an endocrinologist discuss the prevalence and recognition of hyperprolactinemia in patients receiving antipsychotic medications and management strategies for reducing this risk. http://podcast.peerviewpress.com/psychiatry/PA03920FCe005.mp3 http://podcast.peerviewpress.com/psychiatry/PA03920FCe005.mp3 Tue, 23 Oct 2007 16:18:34 -0400 Science no 01:03:13 Antipsychotic, atypical, Aripiprazole, Bipolar disorder, Clozapine, Dopamine, Haloperidol, Hyperprolactinemia, Hypoprolactinemia, Olanzapine, Perphenazine, Pituitary, Prolactin, Quetiapine, Risperidone, Schizophrenia, Ziprasidone PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/psychiatry/PA03920FCCMEinfo.pdf http://podcast.peerviewpress.com/psychiatry/PA03920FCCMEinfo.pdf Tue, 23 Oct 2007 16:18:34 -0400 Science no 00:00:00 Antipsychotic, atypical, Aripiprazole, Bipolar disorder, Clozapine, Dopamine, Haloperidol, Hyperprolactinemia, Hypoprolactinemia, Olanzapine, Perphenazine, Pituitary, Prolactin, Quetiapine, Risperidone, Schizophrenia, Ziprasidone PeerView Press In this activity, psychiatric experts discuss best practices for the management of acute agitation in the emergency setting, which are likely to promote the success of longer-term care. Specifically, the goal of medically calming the acutely agitated patient, without inducing sedation, is advanced to foster voluntary care in the short term and to increase the probability of long-term treatment adherence. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, psychiatric experts discuss best practices for the management of acute agitation in the emergency setting, which are likely to promote the success of longer-term care. Specifically, the goal of medically calming the acutely agitated patient, without inducing sedation, is advanced to foster voluntary care in the short term and to increase the probability of long-term treatment adherence. http://podcast.peerviewpress.com/psychiatry/PA03846FCr312.mp3 http://podcast.peerviewpress.com/psychiatry/PA03846FCr312.mp3 Thu, 16 Aug 2007 16:19:11 -0400 Science no 00:40:34 Agitation, acute,Antipsychotics, atypical,antipsychotics, first-generation,Antipsychotics, second-generation,Antipsychotics, typical,Aripiprazole,Behavioral emergencies,Benzodiazepine,Bipolar disorder,Bipolar episode,Clozapine,Emergency psychiatry PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/psychiatry/PA03846FCCMEinfo.pdf http://podcast.peerviewpress.com/psychiatry/PA03846FCCMEinfo.pdf Thu, 16 Aug 2007 16:18:32 -0400 Science no 00:00:00 Agitation, acute,Antipsychotics, atypical,antipsychotics, first-generation,Antipsychotics, second-generation,Antipsychotics, typical,Aripiprazole,Behavioral emergencies,Benzodiazepine,Bipolar disorder,Bipolar episode,Clozapine,Emergency psychiatry PeerView Press In this CME activity, an expert in the treatment of insomnia discusses recent data on the efficacy and safety on current therapies used in insomnia. Recent data on the impact of these insomnia medications in special populations is also highlighted. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this CME activity, an expert in the treatment of insomnia discusses recent data on the efficacy and safety on current therapies used in insomnia. Recent data on the impact of these insomnia medications in special populations is also highlighted. http://podcast.peerviewpress.com/psychiatry/PA03866FCn163.mp3 http://podcast.peerviewpress.com/psychiatry/PA03866FCn163_2.mp3 Thu, 02 Aug 2007 17:37:54 -0400 Science no 00:18:58 insomnia, elderly, geriatrics, women, psychiatric disorders, ramelteon, eszopiclone, zolpidem, zaleplon, cognitive behavioral therapy, sleep disorders, circadian rhythm disorders, primary sleep disorders, antihistamines, melatonin, valerian root PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/psychiatry/PA03866FCn163.pdf http://podcast.peerviewpress.com/psychiatry/PA03866FCn163.pdf Thu, 02 Aug 2007 17:37:50 -0400 Science no 00:00:00 insomnia, elderly, geriatrics, women, psychiatric disorders, ramelteon, eszopiclone, zolpidem, zaleplon, cognitive behavioral therapy, sleep disorders, circadian rhythm disorders, primary sleep disorders, antihistamines, melatonin, valerian root PeerView Press In this activity, expert physicians discuss how to apply efficacy and safety data derived from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) to the long-term clinical management of schizophrenia. In addition, evidence-based support for the use of psychiatric agents as maintenance therapy in bipolar I disorder is presented. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, expert physicians discuss how to apply efficacy and safety data derived from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) to the long-term clinical management of schizophrenia. In addition, evidence-based support for the use of psychiatric agents as maintenance therapy in bipolar I disorder is presented. http://podcast.peerviewpress.com/psychiatry/PA03789FCe003.mp3 http://podcast.peerviewpress.com/psychiatry/PA03789FCe003.mp3 Thu, 17 May 2007 16:15:54 -0400 Science no 00:42:26 Aripiprazole, clozapine, olanzapine, risperidone, quetiapine, ziprasidone, lithium, lamotrigine, divalproex, perphenazine, schizophrenia, bipolar, bipolar disorder, CATIE, Clinical Antipsychotic Trials of Intervention Effectiveness, dopamine PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/psychiatry/PA03789FCCMEinfo.pdf http://podcast.peerviewpress.com/psychiatry/PA03789FCCMEinfo.pdf Thu, 17 May 2007 16:15:35 -0400 Science no 00:00:00 Aripiprazole, clozapine, olanzapine, risperidone, quetiapine, ziprasidone, lithium, lamotrigine, divalproex, perphenazine, schizophrenia, bipolar, bipolar disorder, CATIE, Clinical Antipsychotic Trials of Intervention Effectiveness, dopamine PeerView Press In this CME/CE activity, experts in the treatment of psychiatric disorders present recent data on the efficacy and safety of the use of atypical antipsychotics in the elderly. Dosing and management issues in this population are also highlighted. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. In this CME/CE activity, experts in the treatment of psychiatric disorders present recent data on the efficacy and safety of the use of atypical antipsychotics in the elderly. Dosing and management issues in this population are also highlighted. http://podcast.peerviewpress.com/psychiatry/PA03599FCr276.mp3 http://podcast.peerviewpress.com/psychiatry/PA03599FCr276.mp3 Thu, 10 May 2007 16:48:58 -0400 Science no 00:36:33 Primary psychotic disorder, chronic or late-onset schizophrenia, late-onset delusional disorders, affective disorders, psychosis from neurodegenerative disorders, Alzheimer's disease, vascular dementia, Lewy body dementia, Parkinson's disease PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/psychiatry/PA03599FCCMEinfo.pdf http://podcast.peerviewpress.com/psychiatry/PA03599FCCMEinfo.pdf Thu, 10 May 2007 16:48:39 -0400 Science no 00:00:00 Primary psychotic disorder, chronic or late-onset schizophrenia, late-onset delusional disorders, affective disorders, psychosis from neurodegenerative disorders, Alzheimer's disease, vascular dementia, Lewy body dementia, Parkinson's disease PeerView Press In this activity, experts discuss issues of dosing and switching atypical antipsychotics in patients with mental illness. Management strategies for weight gain, sedation, and other metabolic effects are featured. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. In this activity, experts discuss issues of dosing and switching atypical antipsychotics in patients with mental illness. Management strategies for weight gain, sedation, and other metabolic effects are featured. http://podcast.peerviewpress.com/psychiatry/PA03288FCe001.mp3 http://podcast.peerviewpress.com/psychiatry/PA03288FCe001.mp3 Fri, 04 May 2007 16:42:03 -0400 Science no 00:53:01 Bipolar disorder, schizophrenia, aripiprazole, clozapine, olanzapine, quetiapine, risperidone, ziprasidone, weight gain, sedation, atypical antipsychotic, side effects, dosing, switching PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/psychiatry/PA03288FCCMEinfo.pdf http://podcast.peerviewpress.com/psychiatry/PA03288FCCMEinfo.pdf Fri, 04 May 2007 16:41:30 -0400 Science no 00:00:00 Bipolar disorder, schizophrenia, aripiprazole, clozapine, olanzapine, quetiapine, risperidone, ziprasidone, weight gain, sedation, atypical antipsychotic, side effects, dosing, switching PeerView Press In this activity, psychiatric experts discuss obstacles to the successful treatment of depression, including the high rate of disease relapse and the potential for drug-drug interactions with antidepressant use. Specifically, the consensus-accepted drug-drug or drug-food interactions of hypertensive crisis and serotonin syndrome are discussed, and tactics for averting these and other antidepressant-associated effects are presented. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. In this activity, psychiatric experts discuss obstacles to the successful treatment of depression, including the high rate of disease relapse and the potential for drug-drug interactions with antidepressant use. Specifically, the consensus-accepted drug-drug or drug-food interactions of hypertensive crisis and serotonin syndrome are discussed, and tactics for averting these and other antidepressant-associated effects are presented. http://podcast.peerviewpress.com/psychiatry/PA03784FCr295.mp3 http://podcast.peerviewpress.com/psychiatry/PA03784FCr295.mp3 Thu, 03 May 2007 10:15:41 -0400 Science no 00:47:04 Antidepressant, Depression, Depression, refractory, Dopamine, Hypertensive crisis, Monoamine oxidase inhibitor (MAOI), Norepinephrine, P450 metabolism, Selective serotonin-reuptake inhibitor (SSRI), Selegiline, Selegiline, transdermal PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/psychiatry/PA03784FCCMEinfo.pdf http://podcast.peerviewpress.com/psychiatry/PA03784FCCMEinfo.pdf Thu, 03 May 2007 10:14:59 -0400 Science no 00:00:00 Antidepressant, Depression, Depression, refractory, Dopamine, Hypertensive crisis, Monoamine oxidase inhibitor (MAOI), Norepinephrine, P450 metabolism, Selective serotonin-reuptake inhibitor (SSRI), Selegiline, Selegiline, transdermal PeerView Press In this CME activity, experts in the treatment of adult ADHD present recent data on efficacy and safety of current and emerging agents used in the treatment of this condition. Diagnosis of this condition is also discussed. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this CME activity, experts in the treatment of adult ADHD present recent data on efficacy and safety of current and emerging agents used in the treatment of this condition. Diagnosis of this condition is also discussed. http://podcast.peerviewpress.com/psychiatry/PA03681FCr282.mp3 http://podcast.peerviewpress.com/psychiatry/PA03681FCr282.mp3 Thu, 26 Apr 2007 11:47:47 -0400 Science no 00:27:00 Adult ADHD, ADHD, DSM-IV, comorbidity, Utah Criteria, ADHD self-report scale (ASRS), mixed amphetamphetine salts, dexmethylphenidate, atomoxetine, antidepressants, psychoeducation, psychotherapy, SPD465, guanfacine, LDX PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/psychiatry/PA03681FCCMEinfo.pdf http://podcast.peerviewpress.com/psychiatry/PA03681FCCMEinfo.pdf Thu, 26 Apr 2007 11:47:21 -0400 Science no 00:00:00 Adult ADHD, ADHD, DSM-IV, comorbidity, Utah Criteria, ADHD self-report scale (ASRS), mixed amphetamphetine salts, dexmethylphenidate, atomoxetine, antidepressants, psychoeducation, psychotherapy, SPD465, guanfacine, LDX PeerView Press In this CME activity, experts in the treatment of schizophrenia and bipolar disorder discuss the use of atypical antipsychotics in treatment and approaches to managing comorbid conditions and suicidal behaviors. The addition of mood stabilizers to atypical antipsychotics for schizophrenia and bipolar disorder is also highlighted. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this CME activity, experts in the treatment of schizophrenia and bipolar disorder discuss the use of atypical antipsychotics in treatment and approaches to managing comorbid conditions and suicidal behaviors. The addition of mood stabilizers to atypical antipsychotics for schizophrenia and bipolar disorder is also highlighted. http://podcast.peerviewpress.com/psychiatry/PA03446FCr251.mp3 http://podcast.peerviewpress.com/psychiatry/PA03446FCr251.mp3 Thu, 28 Dec 2006 09:50:21 -0500 Science no 00:22:43 psychiatry, bipolar disorder, schizophrenia, comorbid conditions, suicide, atypical antipsychotics, clozapine, olanzapine, quetiapine, risperidone, ziprasidone, aripriprazole, bifeprunox, partial agonists, mood stabilizers, lithium, valproate PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/psychiatry/PA03446FCCMEinfo.pdf http://podcast.peerviewpress.com/psychiatry/PA03446FCCMEinfo.pdf Thu, 28 Dec 2006 09:50:01 -0500 Science no 00:00:00 psychiatry, bipolar disorder, schizophrenia, comorbid conditions, suicide, atypical antipsychotics, clozapine, olanzapine, quetiapine, risperidone, ziprasidone, aripriprazole, bifeprunox, partial agonists, mood stabilizers, lithium, valproate PeerView Press In this activity, an expert in the management of patients with bipolar disorder and schizophrenia will use a case-based teaching model to discuss important issues on the use of atypical antipsychotics into the treatment of patients with these conditions. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, an expert in the management of patients with bipolar disorder and schizophrenia will use a case-based teaching model to discuss important issues on the use of atypical antipsychotics into the treatment of patients with these conditions. http://podcast.peerviewpress.com/psychiatry/PA03325FCp110.mp3 http://podcast.peerviewpress.com/psychiatry/PA03325FCp110.mp3 Fri, 22 Dec 2006 17:21:00 -0500 Science no 00:15:16 Bipolar disorder, schizophrenia, atypical antipsychotics, risperidone, aripiprazole, olanzapine, quetiapine, ziprasidone, clozapine, weight gain, sedation, decreased alertness PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/psychiatry/PA03325FCCMEinfo.pdf http://podcast.peerviewpress.com/psychiatry/PA03325FCCMEinfo.pdf Fri, 22 Dec 2006 17:15:06 -0500 Science no 00:00:00 Bipolar disorder, schizophrenia, atypical antipsychotics, risperidone, aripiprazole, olanzapine, quetiapine, ziprasidone, clozapine, weight gain, sedation, decreased alertness PeerView Press In this CME activity, experts in the treatment of ADHD present recent data on efficacy and safety of stimulant medications used in treating this condition. The risk of abuse of stimulant medications is discussed, and the importance of treatment in people with ADHD is highlighted. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this CME activity, experts in the treatment of ADHD present recent data on efficacy and safety of stimulant medications used in treating this condition. The risk of abuse of stimulant medications is discussed, and the importance of treatment in people with ADHD is highlighted. http://podcast.peerviewpress.com/psychology/PA03417FCr257.mp3 http://podcast.peerviewpress.com/psychiatry/PA03417FCr257.mp3 Wed, 20 Dec 2006 16:59:33 -0500 Science no 00:16:14 attention deficit hyperactivity disorder, ADHD, psychostimulants, stimulant medications, nonstimulant, behavioral therapy, lisdexamfetamine, LDX, methylphenidate, amphetamine mixed salts, amphetamine, dexmethylphenidate, SPD465, immediate-release PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/psychology/PA03417FCCMEinfo.pdf http://podcast.peerviewpress.com/psychiatry/PA03417FCCMEinfo.pdf Wed, 20 Dec 2006 16:58:04 -0500 Science no 00:00:00 attention deficit hyperactivity disorder, ADHD, psychostimulants, stimulant medications, nonstimulant, behavioral therapy, lisdexamfetamine, LDX, methylphenidate, amphetamine mixed salts, amphetamine, dexmethylphenidate, SPD465, immediate-release PeerView Press In this activity, experts discuss potential adverse effects from the interaction of atypical antipsychotics at the histamine-1 receptor. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts discuss potential adverse effects from the interaction of atypical antipsychotics at the histamine-1 receptor. http://podcast.peerviewpress.com/psychology/PA03375FCinR203.mp3 http://podcast.peerviewpress.com/psychiatry/PA03375FCinR203.mp3 Mon, 21 Aug 2006 15:14:27 -0400 Science no 00:25:53 Atypical antipsychotic, weight gain, sedation, alertness, histamine, aripiprazole, clozapine, risperidone, olanzapine, quetiapine, ziprasidone PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/psychology/PA03375FCCMEinfo.pdf http://podcast.peerviewpress.com/psychiatry/PA03375FCCMEinfo.pdf Mon, 21 Aug 2006 15:14:22 -0400 Science no 00:00:00 Atypical antipsychotic, weight gain, sedation, alertness, histamine, aripiprazole, clozapine, risperidone, olanzapine, quetiapine, ziprasidone PeerView Press In this activity, experts in the field of psychiatry discuss the impact of receptor mechanisms of action on the development of adverse effects associated with atypical antipsychotics. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the field of psychiatry discuss the impact of receptor mechanisms of action on the development of adverse effects associated with atypical antipsychotics. 1 Tue, 09 May 2006 12:00:00 -0400 Science no 00:24:55 Psychiatry, bipolar disorder, schizophrenia, atypical antipsychotic, antipsychotic, aripiprazole, risperidone, quetiapine, olanzapine, clozapine, ziprasidone, weight gain, sedation, EPS, extrapyramidal symptoms, insomnia, adverse effects, adverse events, dopamine partial agonists, dopamine antagonists, dopamine receptors, hyperprolactinemia, sexual dysfunction, amenorrhea, galactorrhea, low testosterone, prolactin, dopamine, serotonin, histamine, metabolic effects, diabetes, dyslipidemia, hyperlipidemia, muscarinic, adrenergic, weight, anticholinergic PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. 2 Tue, 09 May 2006 12:00:00 -0400 Science no 00:00:00 Psychiatry, bipolar disorder, schizophrenia, atypical antipsychotic, antipsychotic, aripiprazole, risperidone, quetiapine, olanzapine, clozapine, ziprasidone, weight gain, sedation, EPS, extrapyramidal symptoms, insomnia, adverse effects, adverse events, dopamine partial agonists, dopamine antagonists, dopamine receptors, hyperprolactinemia, sexual dysfunction, amenorrhea, galactorrhea, low testosterone, prolactin, dopamine, serotonin, histamine, metabolic effects, diabetes, dyslipidemia, hyperlipidemia, muscarinic, adrenergic, weight, anticholinergic PeerView Press In this activity, experts review the existing literature on the use of atypical antipsychotics for children and adolescents with schizophrenia and bipolar disorder. The use of these agents to manage maladaptive aggression is featured. The adverse effects of the atypical antipsychotics in younger patients are highlighted. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts review the existing literature on the use of atypical antipsychotics for children and adolescents with schizophrenia and bipolar disorder. The use of these agents to manage maladaptive aggression is featured. The adverse effects of the atypical antipsychotics in younger patients are highlighted. http://podcast.peerviewpress.com/psychiatry/PA02244FCinR179.mp3 http://podcast.peerviewpress.com/psychiatry/PA02244FCinR179.mp3 Tue, 25 Apr 2006 15:09:43 -0400 Science no 00:24:23 Schizophrenia,Aggression,Atypical Antipsychotics,Adolescent,ziprasidone,clozapine,valproic acid,extrapyramidal,risperidone,haloperidol,olanzapine,aripiprazole,quetiapine,Akathisia,withdrawal dyskinesia,weight gain,diabetes,Prolactin,sedation PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/psychiatry/PA02244FCCMEinfo.pdf http://podcast.peerviewpress.com/psychiatry/PA02244FCCMEinfo.pdf Tue, 25 Apr 2006 15:09:37 -0400 Science no 00:00:00 Schizophrenia,Aggression,Atypical Antipsychotics,Adolescent,ziprasidone,clozapine,valproic acid,extrapyramidal,risperidone,haloperidol,olanzapine,aripiprazole,quetiapine,Akathisia,withdrawal dyskinesia,weight gain,diabetes,Prolactin,sedation PeerView Press In this activity, experts in the treatment of depression discuss unmet needs of treatment options for this condition, including issues of efficacy and tolerability. The use of emerging monoamine oxidase inhibitors for the treatment of major depression is highlighted. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the treatment of depression discuss unmet needs of treatment options for this condition, including issues of efficacy and tolerability. The use of emerging monoamine oxidase inhibitors for the treatment of major depression is highlighted. http://podcast.peerviewpress.com/psychiatry/PA02293FCinR159.mp3 http://podcast.peerviewpress.com/psychiatry/PA02293FCinR159.mp3 Mon, 27 Mar 2006 11:09:02 -0500 Science no 00:24:36 Tyramine,Transdermal Monoamine Oxidase Inhibitor,monoamine oxidase inhibitor (MAOI),major depression,hypertensive crisis,oral selegiline,transdermal selegiline,antidepressant,side effects,tyramine effect,SSRIs,sexual dysfunction,drug-drug interaction,HAMD PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/psychiatry/PA02293FCCMEinfo.pdf http://podcast.peerviewpress.com/psychiatry/PA02293FCCMEinfo.pdf Mon, 27 Mar 2006 11:08:55 -0500 Science no 00:00:00 Tyramine,Transdermal Monoamine Oxidase Inhibitor,monoamine oxidase inhibitor (MAOI),major depression,hypertensive crisis,oral selegiline,transdermal selegiline,antidepressant,side effects,tyramine effect,SSRIs,sexual dysfunction,drug-drug interaction,HAMD